» Articles » PMID: 38963015

Interrelated Involvement of the Endocannabinoid/endovanilloid (TRPV1) Systems and Epigenetic Processes in Anxiety- and Working Memory Impairment-related Behavioural Effects of Nicotine As a Stressor

Overview
Journal Addict Biol
Specialty Psychiatry
Date 2024 Jul 4
PMID 38963015
Authors
Affiliations
Soon will be listed here.
Abstract

The addictive use of nicotine contained in tobacco is associated with stressor-like emotional and cognitive effects such as anxiety and working memory impairment, and the involvement of epigenetic mechanisms such as histone acetylation has recently been reported. Although the precise nature of behavioural plasticity remains unclear, both anxiogenic- and working memory impairment-like effects were observed in the present experimental model of mice treated with repeated subcutaneous nicotine and/or immobilization stress, and these effects were commonly attenuated by the histone deacetylase (HDAC) inhibitors that induce histone acetylation. Such HDAC inhibitor-induced resilience was mimicked by ligands for the endocannabinoid (ECB) system, a neurotransmitter system that is closely associated with nicotine-induced addiction-related behaviours: the anxiogenic-like effects were mitigated by the cannabinoid type 1 (CB1) agonist arachidonylcyclopropylamide (ACPA), whereas the working memory impairment-like effects were mitigated by the CB1 antagonist SR 141716A. Moreover, the effects of the HDAC inhibitors were also mimicked by ligands for the endovanilloid (transient receptor potential vanilloid 1 [TRPV1]) system, a system that shares common characteristics with the ECB system: the anxiogenic-like effects were mitigated by the TRPV1 antagonist capsazepine, whereas the working memory impairment-like effects were mitigated by the TRPV1 agonist olvanil. Notably, the HDAC inhibitor-induced anxiolytic-like effects were attenuated by SR 141716A, which were further counteracted by capsazepine, whereas the working memory improvement-like effects were attenuated by capsazepine, which were further counteracted by SR 141716A. These results suggest the contribution of interrelated control of the ECB/TRPV1 systems and epigenetic processes such as histone acetylation to novel therapeutic approaches.

References
1.
Back F, Carobrez A . Periaqueductal gray glutamatergic, cannabinoid and vanilloid receptor interplay in defensive behavior and aversive memory formation. Neuropharmacology. 2018; 135:399-411. DOI: 10.1016/j.neuropharm.2018.03.032. View

2.
Stafford J, Raybuck J, Ryabinin A, Lattal K . Increasing histone acetylation in the hippocampus-infralimbic network enhances fear extinction. Biol Psychiatry. 2012; 72(1):25-33. PMC: 3352991. DOI: 10.1016/j.biopsych.2011.12.012. View

3.
Schiltz C, Kelley A, Landry C . Acute stress and nicotine cues interact to unveil locomotor arousal and activity-dependent gene expression in the prefrontal cortex. Biol Psychiatry. 2006; 61(1):127-35. PMC: 1698504. DOI: 10.1016/j.biopsych.2006.03.002. View

4.
Yoshida T, Sakane N, Umekawa T, Kondo M . Effect of nicotine on sympathetic nervous system activity of mice subjected to immobilization stress. Physiol Behav. 1994; 55(1):53-7. DOI: 10.1016/0031-9384(94)90009-4. View

5.
Busquets-Garcia A, Gomis-Gonzalez M, Salgado-Mendialdua V, Galera-Lopez L, Puighermanal E, Martin-Garcia E . Hippocampal Protein Kinase C Signaling Mediates the Short-Term Memory Impairment Induced by Delta9-Tetrahydrocannabinol. Neuropsychopharmacology. 2017; 43(5):1021-1031. PMC: 5854793. DOI: 10.1038/npp.2017.175. View